Actions of epoxygenase metabolites on the preglomerular vasculature.
about
Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted miceSoluble epoxide hydrolase as a therapeutic target for cardiovascular diseasesCellular mediators of renal vascular dysfunction in hypertensionEpoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular functionRole of the adenosine(2A) receptor-epoxyeicosatrienoic acid pathway in the development of salt-sensitive hypertensionThe role of epoxyeicosatrienoic acids in the cardiovascular systemSoluble epoxide hydrolase activity determines the severity of ischemia-reperfusion injury in kidneyTargeting epoxides for organ damage in hypertensionSoluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitorEffect of Soluble Epoxide Hydrolase on the Modulation of Coronary Reactive Hyperemia: Role of Oxylipins and PPARγVariation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary interventionSoluble epoxide hydrolase inhibition modulates vascular remodelingEpoxides and soluble epoxide hydrolase in cardiovascular physiologyBeneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approachesVascular Endothelial Over-Expression of Human Soluble Epoxide Hydrolase (Tie2-sEH Tr) Attenuates Coronary Reactive Hyperemia in Mice: Role of Oxylipins and ω-HydroxylasesInhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal diseaseAssociation of gain-of-function EPHX2 polymorphism Lys55Arg with acute kidney injury following cardiac surgeryEpoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation.A new class of lipid mediators: cytochrome P450 arachidonate metabolitesThe soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke.8,9-Epoxyeicosatrienoic acid inhibits antibody production of B lymphocytes in miceInhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation.Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice.Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats.Epoxyeicosatrienoic acids mediate adenosine-induced vasodilation in rat preglomerular microvessels (PGMV) via A2A receptors.Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.Eicosanoids, β-cell function, and diabetesSoluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles.Contribution of cytochrome P450 epoxygenase and hydroxylase pathways to afferent arteriolar autoregulatory responsiveness11,12,20-Trihydroxy-eicosa-8(Z)-enoic acid: a selective inhibitor of 11,12-EET-induced relaxations of bovine coronary and rat mesenteric arteries.Midkine Regulates BP through Cytochrome P450-Derived Eicosanoids.Epoxyeicosatrienoic acids and endothelium-dependent responses.Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice.Determination of the dominant arachidonic acid cytochrome p450 monooxygenases in rat heart, lung, kidney, and liver: protein expression and metabolite kinetics.Plasma oxylipin profiling identifies polyunsaturated vicinal diols as responsive to arachidonic acid and docosahexaenoic acid intake in growing piglets.Identification of novel endogenous cytochrome p450 arachidonate metabolites with high affinity for cannabinoid receptors.Indapamide lowers blood pressure by increasing production of epoxyeicosatrienoic acids in the kidney.Afferent arteriolar dilation to 11, 12-EET analogs involves PP2A activity and Ca2+-activated K+ Channels.Consequences of perinatal treatment with L-arginine and antioxidants for the renal transcriptome in spontaneously hypertensive rats.
P2860
Q23910189-E4F868E8-3FEF-47E2-BC31-383CB11BA503Q24597172-E89FDA95-59CB-4C07-9994-98E635676A06Q24644250-3E8BB7CE-4F69-4FF0-A22C-1D499344DD62Q26849271-67B47162-0D74-4DAC-86CD-81CABF129520Q27000348-A03ACC1A-A1F8-4498-9AFD-C5058CA8CC56Q28256560-C1025256-B029-4620-8DA5-F3C301A0C4F0Q28384279-4855714C-7BA2-426D-8522-0306988D48B9Q28387558-D84521E1-B365-4580-AE05-19942FEA6FCDQ28387686-7F32B08E-51F2-46F2-BD2F-811CA6047327Q28388202-E5CC184E-DF5B-4DAF-ABB2-CC40E3D645B2Q28391736-1F24CD06-AF17-40AA-AAAF-89B95D6CDEB1Q28394250-09177D13-E41B-4A40-8153-FEFDBCB9A16AQ28396313-B449F8B9-E46B-489E-A5D6-3E1F938E8490Q28397084-F3267E57-2049-496F-B1B8-D4A0068BE5E7Q29248910-D30691AA-A346-4DEC-BBFD-BCB8FE9F9B51Q33652488-88BD25FD-B0DB-4016-8759-9A1DC4B1C63CQ33731887-C951FD62-B95F-4D7B-A8C3-0F715BADE67CQ33904690-0AAAE318-06A4-43A6-A578-520067B1EF0EQ34012822-3EFFD1B2-AE25-4F2F-9F5B-2B8E3CA163E1Q34036182-FA4B1A19-093B-44B3-A4A1-1FED8726A4C1Q34293859-28BB60DE-3E64-4A14-8720-6582C7477FDDQ34339690-E5630612-F585-4776-B325-A272EF683E09Q34355908-EBAE100A-B2BC-421D-A44E-6DC4883D1412Q34378817-E653DC87-EDFB-4B71-806E-0FC8598CAC8CQ34783515-C7039588-C7D1-46DC-97E6-EFDB986A3DDAQ35046119-3B86E060-3B26-408A-83FB-ACE26407A7EDQ35115765-590026FD-82A8-4D3A-995A-458F46BBAA4DQ35129888-9EB7C2D5-6003-49FC-AC84-B81D121A5DD3Q35325991-0606E1FA-3E5F-40BA-943B-85FA9090DF12Q35566470-DA9ABB70-2896-4B55-BD3F-556897A91042Q35900959-F36F4E39-A716-46D6-B1B7-F09CA0E02BB1Q35903066-9E350C24-7802-4D8B-A11C-89A1CE48ADE7Q36027656-A36DFAE7-B433-4858-8EE5-16D08983E977Q36318247-81C028E9-668B-4094-AE7A-D3EBB56C423DQ36502405-C03EECB0-4711-4F39-919A-8F6D2476BB34Q36822568-229DF5F5-1783-4A7B-8D4A-792C4F2402E2Q36861457-FF0252DE-7506-4B62-8827-1D639C966811Q37027050-ACEB662F-348A-4B01-B7C4-E3D3E18E4CE2Q37125720-4B702DE9-06A5-4E70-A601-63097779380FQ37214704-E6830D83-2CE6-4CE6-8544-3CAE90DFE2E6
P2860
Actions of epoxygenase metabolites on the preglomerular vasculature.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Actions of epoxygenase metabolites on the preglomerular vasculature.
@en
Actions of epoxygenase metabolites on the preglomerular vasculature.
@nl
type
label
Actions of epoxygenase metabolites on the preglomerular vasculature.
@en
Actions of epoxygenase metabolites on the preglomerular vasculature.
@nl
prefLabel
Actions of epoxygenase metabolites on the preglomerular vasculature.
@en
Actions of epoxygenase metabolites on the preglomerular vasculature.
@nl
P2093
P1476
Actions of epoxygenase metabolites on the preglomerular vasculature
@en
P2093
P304
P577
1996-11-01T00:00:00Z